Long-term analysis of 2 prospective studies that incorporate mitomycin C into an adjuvant chemoradiation regimen for pancreatic and periampullary cancers

by Kathryn J. Schunke, PhD, Lauren M. Rosati, BS, Marianna Zahurak, MS, Joseph M. Herman, MD, MSc, Amol K. Narang, MD, Irina Usach, Alison P. Klein, MHS, PhD, Charles J. Yeo, MD, Larry T. Korman, BSN, Ralph H. Hruban, MD, John L. Cameron, MD, Daniel A. Laheru, MD, Ross A. Abrams, MD
Published 2018-01-01